Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Mohammad Obaidul Hoque. (2009) DNA methylation changes in prostate cancer: current developments and future clinical implementation. Expert Review of Molecular Diagnostics 9:3, pages 243-257.
Read now
Read now
Articles from other publishers (15)
Xuezhi He, Jing Wang, Jin Chen, Liang Han, Xiyi Lu, Dengshun Miao, Dandan Yin, Qinghe Geng & Erbao Zhang. (2019) lncRNA UCA1 Predicts a Poor Prognosis and Regulates Cell Proliferation and Migration by Repressing p21 and SPRY1 Expression in GC. Molecular Therapy - Nucleic Acids 18, pages 605-616.
Crossref
Crossref
Cuixia Di, Syafrizayanti, Qianjing Zhang, Yuhong Chen, Yupei Wang, Xuetian Zhang, Yang Liu, Chao Sun, Hong Zhang & Jörg D. Hoheisel. (2018) Function, clinical application, and strategies of Pre-mRNA splicing in cancer. Cell Death & Differentiation 26:7, pages 1181-1194.
Crossref
Crossref
Tingting Ai, Jieni Zhang, Xuedong Wang, Xiaowen Zheng, Xueyan Qin, Qian Zhang, Weiran Li, Wei Hu, Jiuxiang Lin & Feng Chen. (2018) DNA methylation profile is associated with the osteogenic potential of three distinct human odontogenic stem cells. Signal Transduction and Targeted Therapy 3:1.
Crossref
Crossref
Nan Yang, Yang Li, Guang Wang, Yin Ding, Yan Jin & Yiquan Xu. (2017) Tumor necrosis factor-α suppresses adipogenic and osteogenic differentiation of human periodontal ligament stem cell by inhibiting miR-21/Spry1 functional axis. Differentiation 97, pages 33-43.
Crossref
Crossref
F Cidre-Aranaz, T G P Grünewald, D Surdez, L García-García, J Carlos Lázaro, T Kirchner, L González-González, A Sastre, P García-Miguel, S E López-Pérez, S Monzón, O Delattre & J Alonso. (2016) EWS-FLI1-mediated suppression of the RAS-antagonist Sprouty 1 (SPRY1) confers aggressiveness to Ewing sarcoma. Oncogene 36:6, pages 766-776.
Crossref
Crossref
Samar Masoumi-Moghaddam, Afshin Amini & David Lawson Morris. (2014) The developing story of Sprouty and cancer. Cancer and Metastasis Reviews 33:2-3, pages 695-720.
Crossref
Crossref
Nan Yang, Guang Wang, Chenghu Hu, Yuanyuan Shi, Li Liao, Songtao Shi, Yan Cai, Shuli Cheng, Xi Wang, Yali Liu, Liang Tang, Yin Ding & Yan Jin. (2013) Tumor necrosis factor α suppresses the mesenchymal stem cell osteogenesis promoter miR-21 in estrogen deficiency-induced osteoporosis. Journal of Bone and Mineral Research 28:3, pages 559-573.
Crossref
Crossref
Xianwen Ren, Yong Wang, Luonan Chen, Xiang-Sun Zhang & Qi Jin. (2013) ellipsoidFN: a tool for identifying a heterogeneous set of cancer biomarkers based on gene expressions. Nucleic Acids Research 41:4, pages e53-e53.
Crossref
Crossref
Jennifer L. Schutzman & Gail R. Martin. (2012) Sprouty genes function in suppression of prostate tumorigenesis. Proceedings of the National Academy of Sciences 109:49, pages 20023-20028.
Crossref
Crossref
A Macià, P Gallel, M Vaquero, M Gou-Fabregas, M Santacana, A Maliszewska, M Robledo, J R Gardiner, M A Basson, X Matias-Guiu & M Encinas. (2011) Sprouty1 is a candidate tumor-suppressor gene in medullary thyroid carcinoma. Oncogene 31:35, pages 3961-3972.
Crossref
Crossref
Wolfgang Goering, Michael Kloth & Wolfgang A. Schulz. 2012. Cancer Epigenetics. Cancer Epigenetics
47
66
.
Hui Liu, Jianzhong Su, Junhua Li, Hongbo Liu, Jie Lv, Boyan Li, Hong Qiao & Yan Zhang. (2011) Prioritizing cancer-related genes with aberrant methylation based on a weighted protein-protein interaction network. BMC Systems Biology 5:1.
Crossref
Crossref
M Darimipourain, S Wang, M Ittmann & B Kwabi-Addo. (2011) Transcriptional and post-transcriptional regulation of Sprouty1, a receptor tyrosine kinase inhibitor in prostate cancer. Prostate Cancer and Prostatic Diseases 14:4, pages 279-285.
Crossref
Crossref
Mukesh Verma, Payal Patel & Mudit Verma. (2011) Biomarkers in Prostate Cancer Epidemiology. Cancers 3:4, pages 3773-3798.
Crossref
Crossref
T.C. Stadler, A. Jung, B. Schlenker, P. Nuhn, J. Ellinger, T. Kirchner, C.G. Stief & P.J. Bastian. (2010) Pyrosequenzierung in der UroonkologiePyrosequencing in uro-oncology. Der Urologe 49:11, pages 1356-1364.
Crossref
Crossref